These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12799196)

  • 1. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.
    Ermolli M; Schumacher M; Lods N; Hammoud M; Marti HP
    Transpl Immunol; 2003; 11(2):137-45. PubMed ID: 12799196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
    Laplante A; Liu D; Demeule M; Annabi B; Murphy GF; Daloze P; Chen H; Béliveau R
    Transpl Int; 2003 Apr; 16(4):262-9. PubMed ID: 12730807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof].
    Zou HQ; Yao J; Wang YX; Wang J; Li D; Wang P
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):981-5. PubMed ID: 16061007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation.
    Ogawa M; Suzuki J; Hishikari K; Takayama K; Tanaka H; Isobe M
    J Am Coll Cardiol; 2008 May; 51(20):1977-85. PubMed ID: 18482668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
    Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
    Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
    Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
    J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinases 2 and 9 in donor liver, cirrhotic liver, and acute rejection after human liver transplantation.
    Kirimlioglu H; Kirimlioglu V; Yilmaz S
    Transplant Proc; 2008 Dec; 40(10):3574-7. PubMed ID: 19100442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermolysin activates equine lamellar hoof matrix metalloproteinases.
    Mungall BA; Pollitt CC
    J Comp Pathol; 2002 Jan; 126(1):9-16. PubMed ID: 11814317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-9 derived from polymorphonuclear neutrophils increases gut barrier dysfunction and bacterial translocation in rat severe acute pancreatitis.
    Mikami Y; Dobschütz EV; Sommer O; Wellner U; Unno M; Hopt U; Keck T
    Surgery; 2009 Feb; 145(2):147-56. PubMed ID: 19167969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis and matrix metalloproteinases in rat renal allografts.
    Inkinen KA; Soots AP; Krogerus LA; Lautenschlager IT; Ahonen JP
    Transpl Int; 2005 May; 18(5):506-12. PubMed ID: 15819797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes.
    Saygili E; Rana OR; Meyer C; Gemein C; Andrzejewski MG; Ludwig A; Weber C; Schotten U; Krüttgen A; Weis J; Schwinger RH; Mischke K; Rassaf T; Kelm M; Schauerte P
    Basic Res Cardiol; 2009 Jul; 104(4):435-48. PubMed ID: 19148693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats.
    Kuroda T; Yoshida Y; Kamiie J; Kovalenko P; Nameta M; Fujinaka H; Yaoita E; Endo T; Ishizuka S; Nakabayashi K; Yamada A; Nagasawa T; Yamamoto T
    Clin Exp Nephrol; 2004 Sep; 8(3):206-15. PubMed ID: 15480897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.
    Berthier CC; Lods N; Joosten SA; van Kooten C; Leppert D; Lindberg RL; Kappeler A; Raulf F; Sterchi EE; Lottaz D; Marti HP
    Kidney Int; 2006 Jan; 69(2):358-68. PubMed ID: 16408127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.